Clinical Trials

Title   NRG GY004
Principal Investigator/ Physician   Rodney Rocconi, MD
Protocol┬áNo.   NRG GY004
Open Date   03/08/2016
Gender   Female
Cancer Site   Ovarian
Status   Open
Sponsor   NRG
Contact Email   MCI Clinical Trials
Summary  

Protocol Title:  "A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer."

Clinical Trails.Gov Link:  https://www.clinicaltrials.gov/ct2/show/study/NCT02446600?term=NRG-GY004&rank=1&show_locs=Y#locn

Email Newsletters

Connect With Us